General
Pfizer coronavirus vaccine rollout in US ramps up as Moderna shot nears FDA approval
A second COVID-19 vaccine has moved to the cusp of US government authorisation as hundreds more hospitals around the country began dispensing shots to their workers in a rapid expansion of the inoculation drive.
Key points:
- The US’s Federal Drug Administration is expected to vote on approving the Moderna vaccine on Thursday local time
- The Moderna vaccine has similar efficacy as the Pfizer shot, but is easier to store
- The US death toll has passed 300,000 and is expected to spike over the holidays
A day after the start of the rollout for Pfizer-BioNTech’s coronavirus shots, the Food and Drug Administration said its preliminary analysis confirmed the effectiveness and safety of the vaccine developed by Moderna and the National Institutes of…
-
Noosa News21 hours agoEx-Townsville mayor Troy Thompson lied about army service, degrees, and cancer, says CCC
-
Noosa News21 hours agoSecurity concerns over Chinese-made Yutong fleet dismissed
-
Noosa News23 hours agoQueensland’s domestic violence policing and policies are being shaped by lived experience
-
Business14 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
